{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:32:44Z","timestamp":1790728364943,"version":"4.1.0"},"reference-count":18,"publisher":"Impact Journals, LLC","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,5,4]]},"DOI":"10.18632\/oncotarget.25215","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:56:54Z","timestamp":1525438614000},"page":"23443-23450","source":"Crossref","is-referenced-by-count":15,"title":["Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed\/refractory mantle cell lymphoma"],"prefix":"10.18632","volume":"9","author":[{"given":"Alessandro","family":"Broccoli","sequence":"first","affiliation":[{"name":"Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Casadei","sequence":"additional","affiliation":[{"name":"Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Morigi","sequence":"additional","affiliation":[{"name":"Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Sottotetti","sequence":"additional","affiliation":[{"name":"Operative Unit of Medical Oncology, IRCCS Fondazione Maugeri, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gotti","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Spina","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology A, National Cancer Institute, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Volpetti","sequence":"additional","affiliation":[{"name":"Department of Hematology, DISM, Azienda Sanitaria Universitaria Integrata, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ferrero","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Molecular Biotechnologies and Scienze for Health, University Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Spina","sequence":"additional","affiliation":[{"name":"Unit of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pisani","sequence":"additional","affiliation":[{"name":"Hematology and Transplantation Unit, Regina Elena National Cancer Institute, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Merli","sequence":"additional","affiliation":[{"name":"Unit of Hematology, Ospedale di Circolo, Fondazione Macchi, Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Paolini","sequence":"additional","affiliation":[{"name":"Hematology Service, Medicine Department, Rovigo Hospital, Rovigo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio Ruggero","family":"Zilioli","sequence":"additional","affiliation":[{"name":"Division of Hematology, Niguarda Ca\u2019 Granda Hospital, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldini","sequence":"additional","affiliation":[{"name":"OncoHematology Unit, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Di Renzo","sequence":"additional","affiliation":[{"name":"Unit of Hematology, Vito Fazzi Hospital, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Tosi","sequence":"additional","affiliation":[{"name":"Hematology Unit, Infermi Hospital Rimini, Rimini, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cascavilla","sequence":"additional","affiliation":[{"name":"IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Molica","sequence":"additional","affiliation":[{"name":"Unit of Oncology\/Hematology, Azienda Ospedaliera \"Pugliese-Ciaccio\", Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Ilariucci","sequence":"additional","affiliation":[{"name":"Unit of Hematology, Arcispedale Santa Maria Nuova di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Matteo","family":"Rigolin","sequence":"additional","affiliation":[{"name":"Unit of Hematology, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D'Al\u00f2","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Universit\u00e0 Cattolica del Sacro Cuore, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vanazzi","sequence":"additional","affiliation":[{"name":"Hemato-Oncology Division, European Institute of Oncology, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Santambrogio","sequence":"additional","affiliation":[{"name":"Unit of Hematology, University-Hospital Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Hematology Unit, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mastrullo","sequence":"additional","affiliation":[{"name":"Unit of Hematology, Ospedale San Gennaro di Napoli, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Castellino","sequence":"additional","affiliation":[{"name":"Unit of Hematology, Ospedale Santa Croce E Carle, Cuneo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Desabbata","sequence":"additional","affiliation":[{"name":"Ematologia Clinica, Ospedale Maggiore, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Scortechini","sequence":"additional","affiliation":[{"name":"Clinica di Ematologia Ospedali Riuniti, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[{"name":"Unit of Hematology, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Morello","sequence":"additional","affiliation":[{"name":"Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Argnani","sequence":"additional","affiliation":[{"name":"Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[{"name":"Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"iii83","DOI":"10.1093\/annonc\/mdu264","article-title":"Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Ladetto","year":"2014","journal-title":"Ann Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0140-6736(15)00667-4","article-title":"Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study","volume":"387","author":"Cho","year":"2016","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2141.2012.09174.x","article-title":"Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur","volume":"158","author":"Lauritzsen","year":"2012","journal-title":"Br J Haematol"},{"key":"4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma","volume":"27","author":"Pfreundschuh","year":"2009","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Radford","year":"2013","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1182\/blood-2015-03-635326","article-title":"Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results","volume":"126","author":"Radford","year":"2015","journal-title":"Blood"},{"key":"7","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle Cell Lymphoma","volume":"34","author":"Wang","year":"2016","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/hon.2380","article-title":"Predictive factors and outcomes for ibrutinib therapy in relapsed\/refractory mantle cell lymphoma-a \u201creal world\u201d study","volume":"35","author":"Costa","year":"2017","journal-title":"Hematol Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2013-09-527853","article-title":"Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy","volume":"123","author":"Mantel","year":"2014","journal-title":"Blood"},{"key":"10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/bjh.14870","article-title":"Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies","volume":"179","author":"Vermeulen","year":"2017","journal-title":"Br J Haematol"},{"key":"11","article-title":"Efficacy and safety of single-agent ibrutinib in patients with mantle cell lymphoma who progressed after bortezomib therapy","volume":"124","author":"Rizo","year":"2014","journal-title":"Blood"},{"key":"12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","article-title":"Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes","volume":"26","author":"Wang","year":"2015","journal-title":"Ann Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1182\/blood-2015-10-673145","article-title":"Postibrutinib outcomes in patients with mantle cell lymphoma","volume":"127","author":"Noto","year":"2016","journal-title":"Blood"},{"key":"14","doi-asserted-by":"publisher","first-page":"14920","DOI":"10.1038\/ncomms14920","article-title":"Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma","volume":"8","author":"Jacobson","year":"2017","journal-title":"Nat Commun"},{"key":"15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13045-017-0537-5","article-title":"Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed\/progressed after or were refractory\/intolerant to ibrutinib (MCL-004)","volume":"10","author":"Martin","year":"2017","journal-title":"J Hematol Oncol"},{"key":"16","article-title":"Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice, the Lenamant Study","volume":"126","author":"Rusconi","year":"2015","journal-title":"Blood"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2503","article-title":"Practical management of ibrutinib in the real life: focus on atrial fibrillation and bleeding","volume":"7","author":"Molica","year":"2018","journal-title":"Hematol Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Lister","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:47:16Z","timestamp":1589042836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":18,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018,5,4]]}},"alternative-id":["25215","29805746"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25215","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]}}}